{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:03:30Z","timestamp":1784106210865,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bursa Uludag University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis A virus (HAV) infection remains a significant cause of acute viral hepatitis worldwide. T\u00fcrkiye has transitioned from historically high endemicity to an intermediate-endemic setting, and the national childhood vaccination program introduced in 2012 has further influenced epidemiological patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 28,067 patients tested for anti-HAV IgG and IgM at Bursa Uluda\u011f University Hospital between 2014 and 2024, a large tertiary-care referral center. Serological assays were performed using chemiluminescent microparticle immunoassays. Results were categorized by age, sex, and year of testing. IgM-positive cases were further evaluated for clinical and laboratory correlation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age was 36.1 years, and 51.7% were male. Overall, anti-HAV IgG seropositivity was 68.97%, ranging from 31.82% in the 21\u201325-year age group to 99.66% among those\u2009\u2265\u200960 years. Children born in 2012 or later (vaccine-eligible cohort) exhibited an anti-HAV IgG seropositivity rate of 93.3%, with no anti-HAV IgM positivity. Anti-HAV IgM was detected in 0.26% (72\/28,067); however, only 19 cases (26.4%) fulfilled the criteria for acute hepatitis A, and 42% occurred in August\u2013September. Remaining IgM reactivity was mostly asymptomatic\/unlikely acute HAV or possible false positivity, frequently accompanied by HBV\/HCV infection, EBV infection, autoimmune disease, or malignancy. Cut-off indices were significantly higher in confirmed acute cases (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Bursa, T\u00fcrkiye, continues to exhibit intermediate HAV endemicity. The childhood vaccination program supports its effectiveness by demonstrating high seropositivity and the absence of IgM positivity in the vaccine-eligible cohort; however, false-positive IgM reactivity underscores the importance of clinical and laboratory confirmation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11845-026-04346-7","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:31:17Z","timestamp":1774956677000},"page":"1463-1470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in Hepatitis A seroprevalence over 11 years and the impact of the National Vaccination Program in Bursa, T\u00fcrkiye"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6257-5422","authenticated-orcid":false,"given":"B\u00fc\u015fra","family":"\u00c7al\u0131\u015f\u0131r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1725-0644","authenticated-orcid":false,"given":"Ay\u015fe Melda","family":"Payasl\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0864-4989","authenticated-orcid":false,"given":"\u0130mran","family":"Sa\u011fl\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"2","key":"4346_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.gtc.2020.01.002","volume":"49","author":"A Abutaleb","year":"2020","unstructured":"Abutaleb A, Kottilil S (2020) Hepatitis A: epidemiology, natural history, unusual clinical manifestations, and prevention. Gastroenterol Clin North Am 49(2):191\u2013199. https:\/\/doi.org\/10.1016\/j.gtc.2020.01.002","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"4346_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2017.08.034","volume":"68","author":"SM Lemon","year":"2018","unstructured":"Lemon SM, Ott JJ, Van Damme P, Shouval D (2018) Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol 68(1):167\u2013184. https:\/\/doi.org\/10.1016\/j.jhep.2017.08.034","journal-title":"J Hepatol"},{"key":"4346_CR3","unstructured":"Centers for Disease Control and Prevention (2024), May 21 Chapter 9: Hepatitis A. In Epidemiology and Prevention of Vaccine-Preventable Diseases (Pink Book). Retrieved December 1, 2025, from https:\/\/www.cdc.gov\/pinkbook\/hcp\/table-of-contents\/chapter-9-hepatitis-a.html"},{"issue":"6","key":"4346_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/BF02849951","volume":"22","author":"AK Leung","year":"2005","unstructured":"Leung AK, Kellner JD, Davies HD (2005) Hepatitis A: a preventable threat. Adv therapy 22(6):578\u2013586. https:\/\/doi.org\/10.1007\/BF02849951","journal-title":"Adv therapy"},{"key":"4346_CR5","doi-asserted-by":"publisher","first-page":"1580863","DOI":"10.3389\/fpubh.2025.1580863","volume":"13","author":"L Zhang","year":"2025","unstructured":"Zhang L, Wang T, Zhou S et al (2025) Update on the global burden of acute viral hepatitis in 2021: addressing health inequalities. Front public health 13:1580863. https:\/\/doi.org\/10.3389\/fpubh.2025.1580863","journal-title":"Front public health"},{"key":"4346_CR6","unstructured":"World Health Organization (2022) Hepatitis A vaccines: WHO position paper\u2014October 2022. Wkly Epidemiol Rec 97(40):493\u2013512. Available from: https:\/\/www.who.int\/publications\/i\/item\/who-wer9740-493-512. (Accessed 01 Dec 2025)"},{"issue":"4","key":"4346_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1440-1746.2006.04232.x","volume":"21","author":"Z Hussain","year":"2006","unstructured":"Hussain Z, Das BC, Husain SA et al (2006) Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination. J Gastroenterol Hepatol 21(4):689\u2013693. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04232.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"4346_CR8","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1186\/s12889-024-20783-4","volume":"24","author":"\u00d6 Karakaya Suzan","year":"2024","unstructured":"Karakaya Suzan \u00d6, Bekta\u015f M, Alt\u0131ndi\u015f M et al (2024) Examining the changes in the prevalence of Hepatitis a in T\u00fcrkiye: systematic review and metaanalysis. BMC Public Health 24(1):3280. https:\/\/doi.org\/10.1186\/s12889-024-20783-4","journal-title":"BMC Public Health"},{"key":"4346_CR9","unstructured":"Ministry of Health, Republic of Turkey (2018) Hepatitis A vaccine application cover letter. Available from: https:\/\/dosyaism.saglik.gov.tr\/Eklenti\/12472,20121008-1509-hskdan-hepatit-a-asisinin-uygulanmasi-hakkinda-yazipdf.pdf?0 (accessed 30 Jan 2025)"},{"key":"4346_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1476-072X-10-57","volume":"10","author":"K Mohd Hanafiah","year":"2011","unstructured":"Mohd Hanafiah K, Jacobsen KH, Wiersma ST (2011) Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr 10:57. https:\/\/doi.org\/10.1186\/1476-072X-10-57","journal-title":"Int J Health Geogr"},{"issue":"5","key":"4346_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6905a1","volume":"69","author":"Centers for Disease Control and Prevention (CDC)","year":"2020","unstructured":"Centers for Disease Control and Prevention (CDC) (2020) Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2020. MMWR Recomm Rep 69(5):1\u201338. https:\/\/doi.org\/10.15585\/mmwr.rr6905a1","journal-title":"MMWR Recomm Rep"},{"key":"4346_CR12","unstructured":"Centers for Disease Control and Prevention (CDC) (2024) Hepatitis A Surveillance Guidance. Available from: https:\/\/www.cdc.gov\/hepatitis\/php\/surveillance-guidance\/hepatitis-a.html (accessed 01 Dec 2025)"},{"issue":"6","key":"4346_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.5144\/0256-4947.2024.386","volume":"44","author":"M Karabey","year":"2024","unstructured":"Karabey M, Alacam S, Karabulut N et al (2024) Hepatitis A virus infection and seroprevalence, Istanbul, Turkey, 2020\u20132023. Ann Saudi Med 44(6):386\u2013393. https:\/\/doi.org\/10.5144\/0256-4947.2024.386","journal-title":"Ann Saudi Med"},{"issue":"3","key":"4346_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.26444\/aaem\/125394","volume":"27","author":"A Yilmaz","year":"2020","unstructured":"Yilmaz A (2020) Hepatitis A seroprevalence in Erzurum, Turkey. Ann Agric Environ Med 27(3):481\u2013484. https:\/\/doi.org\/10.26444\/aaem\/125394","journal-title":"Ann Agric Environ Med"},{"issue":"4","key":"4346_CR15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.14744\/TurkPediatriArs.2020.06982","volume":"55","author":"A\u00d6 Akman","year":"2020","unstructured":"Akman A\u00d6, Burhan BY, Uzun AK, Ta\u015f D (2020) Hepatitis A virus age-specific seroprevalence after the implementation of a Toddlers\u2019 Vaccination in Turkey: Shifting susceptibility to adolescents. Turk pediatri arsivi 55(4):370\u2013375. https:\/\/doi.org\/10.14744\/TurkPediatriArs.2020.06982","journal-title":"Turk pediatri arsivi"},{"key":"4346_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ajem.2020.11.029","volume":"42","author":"S Nourazari","year":"2021","unstructured":"Nourazari S, Davis SR, Granovsky R et al (2021) Decreased hospital admissions through emergency departments during the COVID-19 pandemic. Am J Emerg Med 42:203\u2013210. https:\/\/doi.org\/10.1016\/j.ajem.2020.11.029","journal-title":"Am J Emerg Med"},{"issue":"2","key":"4346_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.33631\/duzcesbed.827142","volume":"11","author":"Y Y\u0131ld\u0131z","year":"2021","unstructured":"Y\u0131ld\u0131z Y, Telatar TG, Baykal M et al (2021) COVID-19 Pandemisi D\u00f6neminde A\u015f\u0131 Reddinin de\u011ferlendirilmesi. D\u00fczce \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Enstit\u00fcs\u00fc Dergisi 11(2):200\u2013205. https:\/\/doi.org\/10.33631\/duzcesbed.827142","journal-title":"D\u00fczce \u00dcniversitesi Sa\u011fl\u0131k Bilimleri Enstit\u00fcs\u00fc Dergisi"},{"issue":"11","key":"4346_CR18","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/23744235.2024.2370975","volume":"56","author":"DM Flichman","year":"2024","unstructured":"Flichman DM, Ridruejo E, Grosso F et al (2024) Seroprevalence of hepatitis A virus among people born before and after implementation of universal vaccination in Argentina. Infect Dis (Lond) 56(11):983\u2013990. https:\/\/doi.org\/10.1080\/23744235.2024.2370975","journal-title":"Infect Dis (Lond)"},{"key":"4346_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268822000309","volume":"150","author":"D Kelly","year":"2022","unstructured":"Kelly D, O\u2019Hare C, McKeown P et al (2022) Detection and control of an ongoing international outbreak of hepatitis A among the Irish Traveller community beginning September 2020. Epidemiol Infect 150:1\u201313. https:\/\/doi.org\/10.1017\/S0950268822000309","journal-title":"Epidemiol Infect"},{"issue":"22","key":"4346_CR20","doi-asserted-by":"publisher","first-page":"1700583","DOI":"10.2807\/1560-7917.ES.2018.23.22.1700583","volume":"23","author":"J Beaut\u00e9","year":"2018","unstructured":"Beaut\u00e9 J, Westrell T, Schmid D et al (2018) Travel-associated hepatitis A in Europe, 2009 to 2015. Euro Surveill 23(22):1700583. https:\/\/doi.org\/10.2807\/1560-7917.ES.2018.23.22.1700583","journal-title":"Euro Surveill"},{"key":"4346_CR21","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1017\/S0950268820000382","volume":"148","author":"K Mellou","year":"2020","unstructured":"Mellou K, Chrysostomou A, Sideroglou T et al (2020) Epidemiology of hepatitis A in Greece in the last decade: management of reported cases and outbreaks and lessons learned. Epidemiol Infect 148:e58. https:\/\/doi.org\/10.1017\/S0950268820000382","journal-title":"Epidemiol Infect"},{"issue":"5","key":"4346_CR22","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2174\/1871526519666191009144848","volume":"20","author":"SAD Manshadi","year":"2020","unstructured":"Manshadi SAD, Alijani N, Salehi M et al (2020) Hepatitis A seroprevalence among patients with chronic hepatitis B infection: A cross-sectional study in Iran during 2016\u20132017. Infect Disord Drug Targets 20(5):748\u2013751. https:\/\/doi.org\/10.2174\/1871526519666191009144848","journal-title":"Infect Disord Drug Targets"},{"issue":"9","key":"4346_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/pathogens10091081","volume":"10","author":"N Kareem","year":"2021","unstructured":"Kareem N, Al-Salahat K, Bakri FG et al (2021) Tracking the epidemiologic shifts in hepatitis A sero-prevalence using age stratification: A cross-sectional study at Jordan University Hospital. Pathogens 10(9):1081. https:\/\/doi.org\/10.3390\/pathogens10091081","journal-title":"Pathogens"},{"issue":"1","key":"4346_CR24","doi-asserted-by":"publisher","first-page":"fmac009","DOI":"10.1093\/tropej\/fmac009","volume":"68","author":"UE Akbulut","year":"2022","unstructured":"Akbulut UE, Arslan E (2022) Hepatitis A seroprevalence in Mogadishu, Somalia. J Trop Pediatr 68(1):fmac009. https:\/\/doi.org\/10.1093\/tropej\/fmac009","journal-title":"J Trop Pediatr"},{"issue":"7","key":"4346_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1128\/CVI.00211-16","volume":"23","author":"ML Landry","year":"2016","unstructured":"Landry ML (2016) Immunoglobulin M for acute infection: true or false? Clin Vaccine Immunol 23(7):540\u2013545. https:\/\/doi.org\/10.1128\/CVI.00211-16","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"4346_CR26","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1515\/med-2021-0336","volume":"16","author":"Y Tan","year":"2021","unstructured":"Tan Y, Chen L (2021) Sustained false-positive results for hepatitis A virus immunoglobulin M: a case report and literature review. Open Med (Wars) 16(1):1311\u20131317. https:\/\/doi.org\/10.1515\/med-2021-0336","journal-title":"Open Med (Wars)"}],"updated-by":[{"DOI":"10.1007\/s11845-026-04521-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000}}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04346-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:03:24Z","timestamp":1784102604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-026-04346-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4346"],"URL":"https:\/\/doi.org\/10.1007\/s11845-026-04346-7","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The age group labels on the x-axis of Figure 1 appear distorted, which compromises the clarity and readability, figure 1 has now been updated. The sentence \"Similarly, a study conducted in an eastern province (Erzurum) study documented high seropositivity across age groups, reaching 99.3% in older adults [14].\" has been revised for clarity. It now reads \"Similarly, a study from Erzurum, an eastern province of T\u00fcrkiye, reported high seropositivity across age groups, with rates reaching 99.3% among older adults [14].\"","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11845-026-04521-w","URL":"https:\/\/doi.org\/10.1007\/s11845-026-04521-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this article declare no conflicts of interest with the work presented in the article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}